Understanding real-world adherence in the directly acting antiviral era: A prospective evaluation of adherence among people with a history of drug use at a community-based program in Toronto, Canada.

@article{Mason2017UnderstandingRA,
  title={Understanding real-world adherence in the directly acting antiviral era: A prospective evaluation of adherence among people with a history of drug use at a community-based program in Toronto, Canada.},
  author={Kate Mason and Zo{\"e} Dodd and Mary Guyton and Paula Tookey and Bernadette Lettner and John Justin Matelski and Sanjeev Sockalingam and Jason Altenberg and Jeff Earl Powis},
  journal={The International journal on drug policy},
  year={2017},
  volume={47},
  pages={202-208}
}
BACKGROUND Direct acting antiviral (DAA) treatments for Hepatitis C (HCV) are now widely available with sustained virologic response (SVR) rates of >90%. A major predictor of response to DAAs is adherence, yet few real-world studies evaluating adherence among marginalized people who use drugs and/or alcohol exist. This study evaluates patterns and factors associated with non-adherence among marginalized people with a history of drug use who were receiving care through a primary care, community… CONTINUE READING
Highly Cited
This paper has 28 citations. REVIEW CITATIONS
Recent Discussions
This paper has been referenced on Twitter 17 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Similar Papers

Loading similar papers…